Aptima HPV assay: Pivotal trial started

Gen-Probe began a U.S. pivotal trial of its Aptima HPV assay in 7,000 women, including those whose Pap smears show atypical squamous cells of undetermined significance (ASC-US) and women aged 30 and u...